• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[法国和西班牙的药物警戒官方系统。巴斯克地区和波尔多两个地区中心的自发报告比较]

[Official systems of pharmacovigilance in France and in Spain. Comparison of spontaneous reporting in two regional centers: Pays Basque and Bordeaux].

作者信息

Aguirre C, Haramburu F

机构信息

Centre de Pharmacovigilance du Pays Basque, Hospital de Galdakao, España.

出版信息

Therapie. 1995 Nov-Dec;50(6):563-9.

PMID:8745957
Abstract

This report compares the drug surveillance systems in France and Spain. The Spanish causality assessment method is explained. The Spanish and French drug surveillance systems are rather similar, but with some variations in the data analysis and differences between causality algorithms used. Spontaneous reporting in two drug surveillance centres, Aquitaine (Bordeaux, France) and in the Spanish Basque Country (SBC) (type of reports, reporting form) is compared. Reports received by the two centres during the year 1992 are presented. The SBC Centre has received more reports and differences in the source and type of effects were observed.

摘要

本报告比较了法国和西班牙的药物监测系统。文中解释了西班牙的因果关系评估方法。西班牙和法国的药物监测系统颇为相似,但在数据分析方面存在一些差异,且所使用的因果关系算法也有所不同。对阿基坦大区(法国波尔多)和西班牙巴斯克地区(SBC)这两个药物监测中心的自发报告(报告类型、报告表格)进行了比较。呈现了两个中心在1992年收到的报告。SBC中心收到的报告更多,且在不良反应的来源和类型方面存在差异。

相似文献

1
[Official systems of pharmacovigilance in France and in Spain. Comparison of spontaneous reporting in two regional centers: Pays Basque and Bordeaux].[法国和西班牙的药物警戒官方系统。巴斯克地区和波尔多两个地区中心的自发报告比较]
Therapie. 1995 Nov-Dec;50(6):563-9.
2
[Joint program of pharmacovigilance in Quebec: comparison with France, Aquitaine and the Basque region].[魁北克药物警戒联合项目:与法国、阿基坦和巴斯克地区的比较]
Therapie. 1996 Sep-Oct;51(5):578-81.
3
[Regional Centers of Pharmacovigilance: a complementary source of efficiency].[地区药物警戒中心:提高效率的补充来源]
Therapie. 1998 Jul-Aug;53(4):397-400.
4
[Organization and results of drug vigilance in France].[法国药物警戒的组织与成果]
Rev Epidemiol Sante Publique. 1994;42(5):416-23.
5
[French system of drug surveillance].[法国药品监测系统]
Bull Acad Natl Med. 1998;182(7):1383-91; discussion 1392-3.
6
[Users of a regional center of pharmacovigilance].[一个地区药物警戒中心的用户]
Therapie. 1993 Sep-Oct;48(5):475-7.
7
Postmarketing hepatic adverse event experience with PEGylated/non-PEGylated drugs: a disproportionality analysis.聚乙二醇化/非聚乙二醇化药物上市后肝脏不良事件经验:不成比例分析
Eur J Gastroenterol Hepatol. 2007 Nov;19(11):934-41. doi: 10.1097/MEG.0b013e3282efa502.
8
Decision support methods for the detection of adverse events in post-marketing data.用于检测上市后数据中不良事件的决策支持方法。
Drug Discov Today. 2009 Apr;14(7-8):343-57. doi: 10.1016/j.drudis.2008.12.012. Epub 2009 Jan 31.
9
Reports of hyperkalemia after publication of RALES--a pharmacovigilance study.RALES发表后的高钾血症报告——一项药物警戒研究。
Pharmacoepidemiol Drug Saf. 2006 Nov;15(11):775-83. doi: 10.1002/pds.1275.
10
[Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].[采用捕获-再捕获法评估“严重”药物不良反应的发生率:图卢兹大学医院的经验]
Bull Acad Natl Med. 2008 Feb;192(2):421-30; discussion 430-1.

引用本文的文献

1
A system for reporting and evaluating adverse drug reactions of herbal medicine in Taiwan from 1998 to 2016.台湾地区 1998 年至 2016 年草药药物不良反应报告与评估体系。
Sci Rep. 2021 Nov 2;11(1):21476. doi: 10.1038/s41598-021-00704-w.
2
Acute adverse reactions to iopromide vs iomeprol: a retrospective analysis of spontaneous reporting from a radiology department.碘普罗胺与碘美普尔急性不良反应比较:放射科自发报告的回顾性分析。
Br J Radiol. 2014 Jan;87(1033):20130511. doi: 10.1259/bjr.20130511. Epub 2013 Nov 4.